|
LOC643837 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.451900E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.997800E-02 |
| Normal-vs-Stage2 |
4.481900E-02 |
| Normal-vs-Stage3 |
2.831800E-01 |
| Normal-vs-Stage4 |
5.854400E-01 |
| Stage1-vs-Stage2 |
2.348400E-01 |
| Stage1-vs-Stage3 |
7.127000E-01 |
| Stage1-vs-Stage4 |
4.067400E-01 |
| Stage2-vs-Stage3 |
1.987030E-01 |
| Stage2-vs-Stage4 |
1.114210E-01 |
| Stage3-vs-Stage4 |
6.480600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.222040E-01 |
| Normal-vs-AfricanAmerican |
1.368630E-01 |
| Normal-vs-Asian |
1.231020E-01 |
| Caucasian-vs-AfricanAmerican |
3.416800E-01 |
| Caucasian-vs-Asian |
4.147200E-01 |
| AfricanAmerican-vs-Asian |
7.950600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.163700E-02 |
| Normal-vs-Female |
5.628500E-02 |
| Male-vs-Female |
4.554000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.592110E-02 |
| Normal-vs-Age(41-60Yrs) |
4.766400E-02 |
| Normal-vs-Age(61-80Yrs) |
4.892600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.399430E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.247800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.219000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.151370E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.976600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.557840E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.114800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.898900E-03 |
| Classical-VS-Follicular |
1.735860E-03 |
| Classical-VS-Other |
2.591800E-01 |
| Classical-VS-Normal |
1.686650E-01 |
| Tall-VS-Follicular |
2.48089999999035E-06 |
| Tall-VS-Other |
9.253800E-02 |
| Tall-VS-Normal |
3.842100E-02 |
| Follicular-VS-Other |
7.951400E-01 |
| Follicular-VS-Normal |
2.238600E-04 |
| Other-VS-Normal |
1.887560E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.736900E-03 |
| Normal-vs-N1 |
7.873600E-01 |
| N0-vs-N1 |
1.336480E-02 |
|
|
